AtaCor Medical Raises $8.8M to Develop Substernal Cardiac Pacing System

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–AtaCor Medical, Inc. ( announced today that it has completed a $8.8M Series A financing. Co-led by Boston-based Broadview Ventures and Israel-based aMoon Ventures, the financing also includes participation from a corporate partner. The investment will support the continued development of AtaCor’s revolutionary extravascular substernal cardiac pacing system.

Link to Press Release